Replies to post #8200 on Tonix Pharmaceuticals Holding Corp (TNXP)

[green maschine]

Besides the anti-SARS-CoV-2 monoclonal antibodies, "Tonix's lead CNS candidate, TNX-102 SL (cyclobenzaprine HCl sublingual tablet), is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022 and interim data expected in the second quarter of 2023."

[subslover]

I doubt it. The stock is a rat and once a rat always a rat.lol